Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Kissei Pharmaceutical Co., Ltd.
  6. Summary
    4547   JP3240600001

KISSEI PHARMACEUTICAL CO., LTD.

(4547)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
2270 2293 2263 2262 2245 Last
45300 53000 39600 48000 90200 Volume
+0.04% +1.01% -1.31% -0.04% -0.75% Change
Estimated financial data (e)
Sales 2022 67 200 M 613 M 613 M
Net income 2022 3 870 M 35,3 M 35,3 M
Net Debt 2022 - - -
P/E ratio 2022 26,9x
Yield 2022 2,49%
Sales 2023 73 850 M 673 M 673 M
Net income 2023 4 555 M 41,5 M 41,5 M
Net Debt 2023 - - -
P/E ratio 2023 22,8x
Yield 2023 2,58%
Capitalization 104 B 943 M 944 M
Capi. / Sales 2022 1,54x
Capi. / Sales 2023 1,40x
Nbr of Employees 1 863
Free-Float 62,7%
More Financials
Company
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new... 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Ratings of Kissei Pharmaceutical Co., Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about KISSEI PHARMACEUTICAL CO., LTD.
03/30KISSEI PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend
FA
03/21KISSEI PHARMACEUTICAL CO., LTD.(TSE : 4547) dropped from FTSE All-World Index
CI
03/05Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on March 4, 2021, ..
CI
03/04Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan annou..
CI
03/04Kissei Pharmaceutical Co., Ltd. announces an Equity Buyback for 700,000 share..
CI
03/04Kissei Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
2020KISSEI PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
FA
2020KISSEI PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend
FA
2020CG Oncology Announces License and Commercialization Agreement with Kissei Pha..
CI
2020CG Oncology, Inc. announced that it expects to receive $59.999999 million in ..
CI
2019KISSEI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2019JCR and Kissei Pharmaceutical Co., Ltd. Receive Marketing Approval for Darbep..
CI
2019KISSEI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2018KISSEI PHARMACEUTICAL : Announcement of in-licensing of technology related to a ..
PU
2018KISSEI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
More news
News in other languages on KISSEI PHARMACEUTICAL CO., LTD.
2020Vifor-Fresenius et Chemocentryx obtiennent l'examen en Europe de l'avacopan
More news
Chart KISSEI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kissei Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KISSEI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 2 245,00 JPY
Average target price 2 640,00 JPY
Spread / Average Target 17,6%
EPS Revisions
Managers and Directors
Mutsuo Kanzawa Chairman & Chief Executive Officer
Yoshio Furihata President, COO & Representative Director
Takahide Kitahara Director, Manager-Finance & Administration
Shinji Kikuchi Director & General Manager-Research
Shigetaka Shimizu Independent Outside Director